Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer

Gynecologic Oncology

Volumn 117, Issue 2, 2010, Pages 234-238

  Resnick, Kimberly E ^a   Frankel, Wendy L ^a   Morrison, Carl D ^b   Fowler, Jeffrey M ^a   Copeland, Larry J ^a   Stephens, Julie ^a   Kim, Kenneth H ^a   Cohn, David E ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Endometrial cancer; Lynch syndrome; Mismatch repair

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PLATINUM; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MISMATCH REPAIR; PRIMARY TUMOR; PRIORITY JOURNAL; TISSUE MICROARRAY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DNA MISMATCH REPAIR; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950273267     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.12.028     Document Type: Article

References (18)

1. Jemal A., Siegel R., Ward E., et al. Cancer Statistics. A Cancer J. Clin. 59 (2009) 225-249
2. Cohn D.E., Frankel W.L., Resnick K.E., et al. Improved survival with an intact DNA mismatch repair system in endometrial cancer. Obstet. Gynecol. 108 (2006) 1208-1215
3. Elsaleh H., Joseph D., Grieu F., Zeps N., Spry N., and Iacopetta B. Association of tumor site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355 (2000) 1745-1750
4. Ribic C.M., Sargent D.J., Moore M.J., et al. Tumor microsattelite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Eng. J. Med. 349 (2003) 247-257
5. Meyers M., Hwang A., Wagner M.W., and Boothman D.A. Special section: impact of the environment on colon cancer (II), Role of DNA mismatch repair in apoptotic responses to therapeutic agents. Environ. Mol. Mutagen. 44 (2004) 249-264
6. Brabec V., and Kasparkova J. Molecular aspects of resistance to antitumor platinum drugs. Drug Resist. Updat. (2002) 147-161
7. Gong J.G., Costanzo A., Yang H.Q., et al. The tyrosine kinase c-abl regulates p73 in apoptotic response to cisplatin induced DNA damage (see comments). Nature 399 6738 (1999) 806-809
8. Aebi S., Kurdi-Haidar B., Gordon R., et al. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56 (1996) 3087-3090
9. Fink D., Nebel S., Aebi S., et al. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 56 (1996) 4881-4886
10. Strathdee G., MacKean M.J., Illand M., and Brown R. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene 18 (1999) 2335-2341
11. Fritzell J.A., Narayanan L., Baker S.M., et al. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. Cancer Res. 57 (1997) 5143-5147
12. Franchitto A., Pichierri P., Piergentili R., Crescenzi M., Bignami M., and Palitti F. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase. Oncogene 57 (2003) 5143-5147
13. Bucci B., D'Agnano, Amendola D., et al. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibition of MLH1 and MSH2 mismatch repair proteins. Clin. Cancer Res. 7 (2005) 2756-2767
14. Giaccia A., and Kastan M. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12 (1998) 2973-2983
15. Zeng M., Narayanan L., Xu X.S., Prolla T.A., Liskay R.M., and Glazer P.M. Ionizing radiation-induced apoptosis via separate Pms2- and p53-dependent pathways. Cancer Res. 60 (2000) 4889-4893
16. Cohn D.E., Resnick K.E., Morrison C.D., et al. DNA mismatch repair and molecular alterations in non-endometrioid endometrial cancers. Abstract Gynecol. Oncol. 101 (2006) S2-S177
17. Hampel H., Frankel W.L., Martin E., et al. Feasibility of screening for lynch syndrome among patients with colon cancer. J. Clin. Oncol. 26 (2008) 5783-5786
18. Vasen H.F.A., Hendriks Y., de Jong A.E., et al. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors. Dis. Markers 20 (2004) 207-213